Neuronal-driven glioma growth requires Gαi1 and Gαi3

Yin Wang1, Yuan-Yuan Liu2, Min-Bin Chen3

  • 1Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, China.

Theranostics
|August 10, 2021
PubMed

Insights

Neuroligin-3 (NLGN3) drives glioma growth by recruiting Gαi1/3 proteins. Inhibiting Gαi1/3 reduces glioma and lung cancer brain metastasis, highlighting Gαi1/3 as a therapeutic target.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cancer signaling pathways

Background:

  • Neuroligin-3 (NLGN3) is implicated in promoting glioma cell growth.
  • G protein alpha subunit i1/3 (Gαi1/3) recruitment to receptor tyrosine kinases (RTKs) is crucial for oncogenic signaling.

Purpose of the Study:

  • To investigate the role of Gαi1/3 in NLGN3-mediated glioma cell growth and signaling.
  • To determine if Gαi1/3 is a potential therapeutic target for glioma and brain metastasis.

Main Methods:

  • Genetic strategies including shRNA-mediated depletion and ectopic overexpression of Gαi1/3.
  • Analysis of Akt-mTORC1 and Erk signaling pathway activation.
  • Assessment of glioma cell growth, proliferation, and migration in vitro.
  • Evaluation of tumor growth in orthotopic xenograft models (glioma and brain-metastatic lung cancer) in mice.

Main Results:

  • NLGN3-induced Akt-mTORC1 and Erk activation were dependent on Gαi1/3 expression levels.
  • Gαi1/3 depletion attenuated NLGN3-driven glioma cell growth, proliferation, and migration.
  • Gαi1/3 silencing inhibited orthotopic glioma and brain metastasis growth, while overexpression enhanced it.
  • Gαi3 upregulation in human glioma correlated with poor prognosis.

Conclusions:

  • Gαi1/3 is essential for NLGN3-induced oncogenic signaling and glioma cell growth.
  • Targeting Gαi1/3 presents a promising therapeutic strategy for glioma and brain metastasis.

Related Concept Videos

Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
8.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.6K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
13.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K